The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

35 articles for Y Inoue


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.EBI
Kanebo
Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.EBI
Dainippon Sumitomo Pharma
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.EBI
Takeda Pharmaceutical
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.EBI
Nippon Organon K.K.
Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model.EBI
Nippon Organon K.K.
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.EBI
Kanebo
Studies on selectin blockers. 6. Discovery of homologous fucose sugar unit necessary for E-selectin binding.EBI
Kanebo
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.EBI
Institute of Cancer Research
Studies on antiulcer drugs. 7. 2-Guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury.EBI
Fujisawa Pharmaceutical
Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E2 synthase-1 inhibitors.EBI
Dainippon Sumitomo Pharma
Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.EBI
Hokkaido Collaboration Center N-21
Synthesis and biological activity of selective azasugar-based TACE inhibitors.EBI
Organon K.K.
Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.EBI
Hokkaido Collaboration Center
Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.EBI
Hokkaido Collaboration Center
Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).EBI
Organon K.K.
Design and synthesis of peptide-based carboxylic acid-containing transition-state inhibitors of human neutrophil elastase.EBI
Dainippon Pharmaceutical
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.EBI
Organon K.K.
An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.EBI
Nagoya Citi University
Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.EBI
Green Cross Research Laboratories
Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites.EBI
Green Cross Research Laboratories
Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M(1) and M(4) muscarinic acetylcholine receptors agonists.EBI
Dainippon Sumitomo Pharma
CompoundsBDB
Astex Therapeutics
Pyrrolotriazine kinase inhibitorsBDB
Bristol-Myers Squibb
Small molecule activators of NRF2 pathwayBDB
The General Hospital
Bicyclic heterocycles as bet protein inhibitorsBDB
Incyte
Ether compounds for treatment of complement mediated disordersBDB
Achillion Pharmaceuticals
RAF kinase modulator compounds and methods of use thereofBDB
Ambit Biosciences
Kinase inhibitors and methods of their useBDB
Novartis
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.BDB
Abbott Laboratories
1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.BDB
Procter & Gamble Pharmaceuticals
Synthesis, pharmacological evaluation, and molecular modeling studies of novel peptidic CAAX analogues as farnesyl-protein-transferase inhibitors.BDB
Universita Di Napoli Federico Ii
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.BDB
University of Washington At Seattle
2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase iBDB
Bristol-Myers Squibb
Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic.BDB
University of Michigan
Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.BDB
University of Michigan